Trade Summary

2 months ago, Vitoc Vlad, serving as CEO, 10% owner at Maia Biotechnology, Inc. (MAIA), purchased 72,000 shares at $1.11 per share, for a total transaction value of $79,849.00. Following this transaction, Vitoc Vlad now holds 1,063,421 shares of MAIA.

This purchase represents a 7.00% increase in Vitoc Vlad's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, November 28, 2025 and publicly disclosed via SEC Form 4 filing on Monday, December 1, 2025, 3 days after the trade was made.

Maia Biotechnology, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.